REGULATED PRESS RELEASE published on 04/08/2025 at 08:30, 10 months 6 days ago Cie du Bois Sauvage: Buy back of own shares – week from 31/03/2025 to 04/04/2025 Cie du Bois Sauvage disclosed its share buy-back transactions from 31/03/2025 to 04/04/2025, totaling 544 shares purchased for €129,574.00. Details available on www.bois-sauvage.be Cie Du Bois Sauvage Share Buy-back NYSE Euronext Market Brussels Trading Regulation
REGULATED PRESS RELEASE published on 04/08/2025 at 08:15, 10 months 6 days ago Publication of the CNP Assurances Group and CNP Assurances SA Solo SFCRs at 31 December 2024 CNP Assurances Group and CNP Assurances SA release the solo SFCRs for 31 December 2024, meeting Solvency II requirements. Key points include SCR coverage ratios and financial data CNP Assurances Regulatory Compliance Financial Report SFCR Solvency
PRESS RELEASE published on 04/08/2025 at 08:00, 10 months 6 days ago Transaction in Own Shares Molten Ventures plc announces transaction in own shares as part of share repurchase program. Numis Securities bought 70,000 Ordinary Shares, highest price 235.00p, lowest 215.60p Ordinary Shares Molten Ventures Plc Numis Securities Share Repurchase Program Price
PRESS RELEASE published on 04/08/2025 at 08:00, 10 months 6 days ago Pulsar Helium Announces Execution of US$4 Million Project Finance Facility Line of Credit Note Pulsar Helium Inc. secures US$4 million project finance facility for Topaz Helium project in Minnesota from University Bancorp, Inc Pulsar Helium Inc. Topaz Helium Project Minnesota Finance Facility University Bancorp
PRESS RELEASE published on 04/08/2025 at 08:00, 10 months 6 days ago Quantum Genomics provides an update on its situation Quantum Genomics provides an update on trading suspension, search for a new business partner, and financial situation with impending yearly accounts release Financial Situation Trading Suspension Quantum Genomics Reverse Take Over Yearly Accounts Release
PRESS RELEASE published on 04/08/2025 at 08:00, 10 months 6 days ago Ondine Biomedical Inc. Announces Steriwave in First Swiss Hospital University Hospital Zurich conducts independent study on Steriwave for preoperative nasal decolonization, assessing efficacy in reducing microbial burden to combat surgical site infections (SSI) Nasal Decolonization Steriwave Clinical Study University Hospital Zurich Antimicrobial Photodynamic Therapy
PRESS RELEASE published on 04/08/2025 at 07:43, 10 months 6 days ago INSIDE INFORMATION / OTHER NEWS RELEASES GenSight Biologics announces the filing of its 2024 Universal Registration Document with the French market authority, including financial reports and corporate governance details GenSight Biologics Gene Therapies Retinal Neurodegenerative Diseases 2024 Universal Registration Document Central Nervous System Disorders
PRESS RELEASE published on 04/08/2025 at 07:30, 10 months 6 days ago Inside Information / Other news releases MaaT Pharma announces positive safety interim analysis from DSMB for Phase 2b trial evaluating MaaT033 for patients receiving Allo-HSCT, demonstrating favorable safety profile and tolerability Phase 2B Trial MaaT Pharma Safety Analysis MaaT033 Allo-HSCT
PRESS RELEASE published on 04/08/2025 at 07:00, 10 months 6 days ago BIOVERSYS TO PRESENT BV100 PHASE 2 DATA AT 35TH ESCMID GLOBAL 2025 BioVersys to present BV100 Phase 2 data at 35th ESCMID Global 2025. Oral presentation on positive VABP trial read-out & poster presentations on Acinetobacter baumannii & NTM data Clinical Data BV100 Antibacterial Products BioVersys ESCMID Global 2025
PRESS RELEASE published on 04/08/2025 at 07:00, 10 months 6 days ago Nyxoah Provides Update on FDA Approvable Letter for Genio System Nyxoah provides update on FDA Approvable Letter for Genio System, expecting full PMA approval in Q2 2025 after addressing final requirements FDA Nyxoah Genio System Approvable Letter PMA Approval
Published on 02/14/2026 at 01:00, 18 hours ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 20 hours 45 minutes ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 1 hour ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 4 hours ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 16:30, 2 hours 30 minutes ago Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 12 hours 55 minutes ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 23 hours 40 minutes ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 23 hours 59 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:05, 1 day ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 1 hour ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:34, 1 day 1 hour ago Statement of transactions in own shares from February 2, 2026 to February 6, 2026
Published on 02/13/2026 at 07:00, 1 day 12 hours ago Safran reports excellent financial performance in 2025 and raises its 2028 ambitions
Published on 02/12/2026 at 21:30, 1 day 21 hours ago Aéroports de Paris SA - 2026 Airport charges in Paris
